WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer

Poujade, Flore-Anne; Mannion, Aarren; Brittain, Nicholas; Theodosi, Andrew; Beeby, Ellie; Leszczynska, Katarzyna B.; Hammond, Ester M.; Greenman, John; Cawthorne, Christopher; Pires, Isabel M.

doi:10.1038/s41416-018-0056-3

All Outputs (3)

Natural Products as a Source for New Leads in Cancer Research and Treatment (2018)
Journal Article
Cabral, C., Efferth, T., Pires, I. M., Severino, P., & Lemos, M. F. (2018). Natural Products as a Source for New Leads in Cancer Research and Treatment. Evidence-based complementary and alternative medicine : eCAM, 2018, 1-2. https://doi.org/10.1155/2018/8243680

Anticancer properties of essential oils and other natural products (2018)
Journal Article
Blowman, K., Magalhães, M., Lemos, M. F., Cabral, C., & Pires, I. M. (2018). Anticancer properties of essential oils and other natural products. Evidence-based complementary and alternative medicine : eCAM, 2018, 1-12. https://doi.org/10.1155/2018/3149362

Essential oils are secondary metabolites with a key-role in plants protection, consisting primarily of terpenes with a volatile nature and a diverse array of chemical structures. Essential oils exhibit a wide range of bioactivities, especially antimi... Read More about Anticancer properties of essential oils and other natural products.

WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer (2018)
Journal Article
Poujade, F., Mannion, A., Brittain, N., Theodosi, A., Beeby, E., Leszczynska, K. B., …Pires, I. M. (2018). WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer. The British Journal of Cancer, 118(9), 1229-1237. https://doi.org/10.1038/s41416-018-0056-3

© 2018 Cancer Research UK. Background: Metastatic spread is responsible for the majority of cancer-associated deaths. The tumour microenvironment, including hypoxia, is a major driver of metastasis. The aim of this study was to investigate the role o... Read More about WSB-1 regulates the metastatic potential of hormone receptor negative breast cancer.